KOSPI · Healthcare · ₩196B
₩1,050-2.14%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 18.2% · as of 26.09.11
Among 98 제약 peers
Quarterly Revenue Growth
“주력 의약품과 수출이 다음 성장의 방향을 보여줘요.”
In the company's words · 2026 2분기 filing